ST
SONIRE Therapeutics Inc.
SEC filingOther Health Care · Palo Alto, CA
Amount raised$13.5Msold at filing
Total offering$13.5M
Investors in the raise1count reported to the SEC
FiledApr 15, 2026first sale Mar 31, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Dennis McWilliamsDirector
Tohru SatohExecutive Officer, Director, Promoter
Koji YasudaDirector
Jun OkamotoDirector
Auriel AugustDirector
Executive officers, directors and promoters as listed on the Form D.